drugset / Trial / NCT07577050
A Phase II Study of NB001 for Acute Migraine Treatment
Phase 2
Not yet recruiting
120 enrolled
Chinese PLA General Hospital
940 Hospital of the People's Liberation Army Joint Logistic Support Force · collabFirst Affiliated Hospital Xi'an Jiaotong University · collabFirst Affiliated Hospital of Chongqing Medical University · collabFujian Medical University Union Hospital · collabGuangdong Provincial People's Hospital · collabHebei Provincial People's Hospital · collabJiangsu Province Nanjing Brain Hospital · collabNanjing Brain Hospital · collabPeking Union Medical College Hospital · collabPeople's Hospital of Wuhan University · collabRenmin Hospital of Wuhan University · collabSecond Xiangya Hospital of Central South University · collabShandong Provincial Hospital · collabThe Affiliated Hospital of Qingdao University · collabThe First Affiliated Hospital of Dalian Medical University · collabThe First Affiliated Hospital of Xiamen University · collabThe First Affiliated Hospital with Nanjing Medical University · collabThe First Hospital of Jilin University · collabThe Second Affiliated Hospital of Air Force Military Medical University · collabThe Second Affiliated Hospital of Army Medical University · collabXiangya Hospital of Central South University · collabXinhua Hospital, Shanghai Jiao Tong University School of Medicine · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The goal of this observational study is to Evaluate the Efficacy and Safety of NB001 for the Acute Treatment of Migraine in Adult patients diagnosed with migraine.
Timeline
- Start
- 2026-04-20
- Primary completion
- 2026-09-30
- Completion
- 2026-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NB-001 | Other / unclassified | 1 unknown | — |
| Subject | NB-001 | Other / unclassified | 2 unknown | — |
| Subject | NB-001 | Other / unclassified | 4 unknown | — |